Search

  5. ProQR Announces Presentations at the OTS Annual Meeting

    Press release

    … the Netherlands, Sept. 24, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … diseases, today announced upcoming presentations at the Oligonucleotide Therapeutics Society (OTS) annual meeting to be held from September 30 – …

  6. ProQR Announces Financial Results for the Third Quarter of 2018

    Press release

    … CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company … $104.1 million. Delivered two presentations at the Oligonucleotide Therapeutics Society (OTS) conference on clinical data for QR-110 in …

  8. ProQR Announces Results for the Third Quarter of 2017

    Press release

    … interim data also expected in 2018. Spin-out of Amylon Therapeutics as a privately-held company focused on central … Axiomer ® RNA editing technology platform at the Oligonucleotide Therapeutics Society (OTS) meeting in Bordeaux, France and at the Drug …